Therapeutic Drug Monitoring of Beta-lactams and Renal Hyperclearance in Patients Admitted to Intensive Care for Acute Brain Injury
RecruitingOBSERVATIONAL
Enrollment
140
Participants
Timeline
Start Date
May 5, 2025
Primary Completion Date
November 30, 2025
Study Completion Date
December 31, 2025
Conditions
Critical IllnessBrain Injuries
Trial Locations (1)
30029
RECRUITING
CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes
All Listed Sponsors
lead
Centre Hospitalier Universitaire de Nīmes
OTHER
NCT06999161 - Therapeutic Drug Monitoring of Beta-lactams and Renal Hyperclearance in Patients Admitted to Intensive Care for Acute Brain Injury | Biotech Hunter | Biotech Hunter